Sarepta Therapeutics, Inc. Research And Development Expense

Quick Answer

Sarepta Therapeutics, Inc. reported Research And Development Expense of $401.84 million for the year ending 2018.

  • Sarepta Therapeutics, Inc. showed an increase of +141.0% in Research And Development Expense from 2017 to 2018.
  • This data is from Sarepta Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on February 28, 2019.
  • XBRL data for this metric is available from 2009 to 2018 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2009 to 2018), Sarepta Therapeutics, Inc.'s Research And Development Expense has grown by 1,547.2%.
  • Historical annual values: Fiscal year 2018: $401.84 million | Fiscal year 2017: $166.71 million | Fiscal year 2016: $188.27 million | Fiscal year 2015: $146.39 million | Fiscal year 2014: $94.23 million | Fiscal year 2013: $72.91 million | Fiscal year 2012: $52.40 million | Fiscal year 2011: $66.86 million | Fiscal year 2010: $35.97 million | Fiscal year 2009: $24.40 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: